AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
2.650
-0.060 (-2.21%)
At close: Aug 28, 2026, 4:00 PM EDT
2.680
+0.030 (1.13%)
After-hours: Aug 28, 2026, 7:55 PM EDT
AC Immune Market Cap
AC Immune has a market cap or net worth of $263.48 million as of August 28, 2026. Its market cap has increased by 26.49% in one year.
Market Cap
263.48M
Enterprise Value
175.29M
1-Year Change
26.49%
Ranking
Category
Stock Price
$2.65
ChartMarket Cap Chart
Since September 23, 2016, AC Immune's market cap has decreased from $867.50M to $263.48M, a decrease of -69.63%. That is a compound annual growth rate of -11.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 269.60M | -14.90% |
| Dec 31, 2025 | 316.80M | 17.51% |
| Dec 31, 2024 | 269.60M | -36.36% |
| Dec 29, 2023 | 423.60M | 145.85% |
| Dec 30, 2022 | 172.30M | -52.25% |
| Dec 31, 2021 | 360.80M | -2.88% |
| Dec 31, 2020 | 371.50M | -35.46% |
| Dec 31, 2019 | 575.60M | 6.20% |
| Dec 31, 2018 | 542.00M | -25.42% |
| Dec 29, 2017 | 726.70M | 1.07% |
| Dec 30, 2016 | 719.00M | -17.12% |
| Sep 23, 2016 | 867.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 269.41M |
| Sionna Therapeutics | 265.40M |
| Surrozen | 263.51M |
| Whitehawk Therapeutics | 263.38M |
| MacroGenics | 263.08M |
| Alector | 261.28M |
| Neumora Therapeutics | 261.18M |
| Niagen Bioscience | 260.87M |